China has solidified its position as one of Bayer’s most important strategic pillars, as the global life sciences company showcases its innovations at the 7th China International Import Expo (CIIE) in Shanghai from November 5 to 10.
As a returning participant for seven consecutive years, Bayer has not only witnessed the dynamic growth of the Chinese market but has also deepened its collaborations with global partners through the CIIE platform. This year’s expo, themed “New Era, Shared Future,” offers new opportunities for countries and regions worldwide.
“For Bayer, the 7th CIIE is a great opportunity to showcase our innovative products and cutting-edge technology while engaging with a wide spectrum of partners on this one-of-a-kind platform,” said Bill Anderson, CEO of Bayer.
Leveraging the “incubator” effect of the CIIE, Bayer has exhibited over 100 innovative items, nurtured eight “CIIE babies,” and signed over 30 major agreements across various fields over the past six years. The company’s sustained participation underscores its commitment to the Chinese market and its role in fostering global economic cooperation.
The CIIE serves as a window for China to build a new development pattern and a platform for promoting high-level opening-up. By bringing together businesses and leaders from around the globe, the expo facilitates in-depth communication and cooperation, driving innovation and shared growth.
As Bayer continues to strengthen its strategic presence in China, the company remains focused on delivering innovative solutions and contributing to the health and nutrition sectors. The ongoing engagement at the CIIE reflects Bayer’s dedication to a shared future of collaboration and advancement in the new era.
Reference(s):
cgtn.com
